WEHI-539

WEHI-539 (订货以英文为准)

编号:W125716
CAS号:1431866-33-9
分子式:C31H29N5O3S2
分子量:583.72
货号 品牌 包装 目录价 您的价格 库存 数量 购买
W125716-10mg 阿拉丁 10mg ¥2298.90
W125716-5mg 阿拉丁 5mg ¥1631.90
W125716-50mg 阿拉丁 50mg ¥8812.90
产品名称 WEHI-539
中文名称 WEHI-539
CAS号 1431866-33-9
分子式(M.F.) C31H29N5O3S2
分子量(M.W.) 583.72
储存条件 -20°C储存
溶解性25°C: DMSO
存贮条件储存温度-20°C
生化机理Description:IC50 Value: 1.1 nM (BCL-XL) [1]The prosurvival BCL-2 family protein BCL-XL is often overexpressed in solid tumors and renders malignant tumor cells resistant to anticancer therapeutics. The optimized compound, WEHI-539, has high affinity (subnanomolar) and selectivity for BCL-XL and potently kills cells by selectively antagonizing its prosurvival activity.WEHI-539 has a high affinity for BCL-XL (IC50 = 1.1 nM). WEHI-539 interacts with residues in the P4 pocket and adopts a distinct binding mode compared to ABT-737. WEHI-539 induces apoptosis in MEFs only if they lack MCL-1 supports the notion that cell killing induced by WEHI-539 is due to direct inhibition of BCL-XL. Accordingly, restoring expression of MCL-1 in mcl-1 knockout cells renders them highly resistant to WEHI-539. WEHI-539 could only kill cells that contained BAK (Fig. 6b). This observation was confirmed in MEFs where both the amount and activity of MCL-1 were abrogated by expression of its natural and selective BH3-only ligand NOXA. Cytochrome c release and caspase-3 processing confirmed that WEHI-539 induces apoptosis in BAX-deficient MEF cells expressing BIM2A but not in their BAK-deficient counterparts. Remarkably, WEHI-539 efficiently triggered the killing of platelets purified from mice or humans in culture.
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:9012-76-4
¥ 88.00 C953753-100g
¥ 2750.00 sh246789-100kg
CAS号:40516-57-2
¥ 75.00 C826129-250mg
CAS号:72899-92-4
¥ 117.00 BD01089450-250mg
¥ 128.00 sh7651-500mL
¥ 128.00 sh8754-500mL
¥ 128.00 sh42798-500mL
CAS号:1611-83-2
¥ 180.00 27712B-5g
¥ 128.00 sh54098-500mL